Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2015 16:15 ET | Source: Nexvet Biopharma plc

Nexvet Biopharma Reports Full Year Fiscal 2015 Results

DUBLIN, Ireland, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced financial results for its 2015 fiscal year, which concluded on June...
July 07, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet and Zenoaq Enter Research and Development Collaboration

DUBLIN, Ireland, July 7, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced the signing of a research and development agreement with leading...
June 10, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Present at the JMP Securities Life Sciences Conference 2015

DUBLIN, Ireland and MELBOURNE, Australia, June 10, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced that Dr. Mark Heffernan, Nexvet's...
June 08, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Advances Manufacturing Strategy

Agreement signed with FUJIFILM Diosynth Biotechnologies Key appointment made in Ireland DUBLIN, Ireland and MELBOURNE, Australia, June 8, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma...
June 04, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Announces Positive Top-Line Results for Proof-of-Concept Efficacy Study of NV-02 in Cats With Degenerative Joint Disease

DUBLIN, Ireland and MELBOURNE, Australia, June 4, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologics developer, today announced statistically significant top-line results...
May 11, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Appoints Dr. Jurgen Horn as Chief Product Development Officer

DUBLIN, Ireland and MELBOURNE, Australia, May 11, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced it has appointed former Elanco and...
May 08, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2015

DUBLIN, Ireland and MELBOURNE, Australia, May 8, 2015 (GLOBE NEWSWIRE) -- Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced its financial results for the three and...
May 07, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet to Present at the Bank of America Merrill Lynch 2015 Health Care Conference

DUBLIN, Ireland and MELBOURNE, Australia, May 7, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, today announced that Dr. Mark Heffernan, Nexvet's...
April 15, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Provides Update on NV-01 Program

DUBLIN, Ireland and MELBOURNE, Australia, April 15, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapy developer, announced today an update on its development...
April 01, 2015 05:30 ET | Source: Nexvet Biopharma plc

Nexvet Biopharma Appoints Dr. George Gunn as Chairman

DUBLIN, Ireland and MELBOURNE, Australia, April 1, 2015 (GLOBE NEWSWIRE) -- Veterinary biologic therapy developer Nexvet Biopharma (Nasdaq:NVET) today announced it has appointed former Division...